Albinda, Jay Ann T.

HRN: 24-72-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
CO-AMOXICLAV 625MG (TAB)
01/31/2026
02/07/2026
PO
625mg
BID X 7 Days
S/P Partial Breech Extraction With Episiotomy
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines